IBDEI1P1 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28335,2)
 ;;=^5002454
 ;;^UTILITY(U,$J,358.3,28336,0)
 ;;=D86.86^^132^1330^39
 ;;^UTILITY(U,$J,358.3,28336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28336,1,3,0)
 ;;=3^Sarcoid Arthropathy
 ;;^UTILITY(U,$J,358.3,28336,1,4,0)
 ;;=4^D86.86
 ;;^UTILITY(U,$J,358.3,28336,2)
 ;;=^5002451
 ;;^UTILITY(U,$J,358.3,28337,0)
 ;;=D86.87^^132^1330^43
 ;;^UTILITY(U,$J,358.3,28337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28337,1,3,0)
 ;;=3^Sarcoid Myositis
 ;;^UTILITY(U,$J,358.3,28337,1,4,0)
 ;;=4^D86.87
 ;;^UTILITY(U,$J,358.3,28337,2)
 ;;=^5002452
 ;;^UTILITY(U,$J,358.3,28338,0)
 ;;=D86.3^^132^1330^49
 ;;^UTILITY(U,$J,358.3,28338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28338,1,3,0)
 ;;=3^Sarcoidosis of Skin
 ;;^UTILITY(U,$J,358.3,28338,1,4,0)
 ;;=4^D86.3
 ;;^UTILITY(U,$J,358.3,28338,2)
 ;;=^5002445
 ;;^UTILITY(U,$J,358.3,28339,0)
 ;;=D86.81^^132^1330^41
 ;;^UTILITY(U,$J,358.3,28339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28339,1,3,0)
 ;;=3^Sarcoid Meningitis
 ;;^UTILITY(U,$J,358.3,28339,1,4,0)
 ;;=4^D86.81
 ;;^UTILITY(U,$J,358.3,28339,2)
 ;;=^5002446
 ;;^UTILITY(U,$J,358.3,28340,0)
 ;;=D86.82^^132^1330^50
 ;;^UTILITY(U,$J,358.3,28340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28340,1,3,0)
 ;;=3^Sarcoidosis,Multiple Cranial Nerve Palsies
 ;;^UTILITY(U,$J,358.3,28340,1,4,0)
 ;;=4^D86.82
 ;;^UTILITY(U,$J,358.3,28340,2)
 ;;=^5002447
 ;;^UTILITY(U,$J,358.3,28341,0)
 ;;=D86.84^^132^1330^44
 ;;^UTILITY(U,$J,358.3,28341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28341,1,3,0)
 ;;=3^Sarcoid Pyelonephritis
 ;;^UTILITY(U,$J,358.3,28341,1,4,0)
 ;;=4^D86.84
 ;;^UTILITY(U,$J,358.3,28341,2)
 ;;=^5002449
 ;;^UTILITY(U,$J,358.3,28342,0)
 ;;=D86.85^^132^1330^42
 ;;^UTILITY(U,$J,358.3,28342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28342,1,3,0)
 ;;=3^Sarcoid Myocarditis
 ;;^UTILITY(U,$J,358.3,28342,1,4,0)
 ;;=4^D86.85
 ;;^UTILITY(U,$J,358.3,28342,2)
 ;;=^5002450
 ;;^UTILITY(U,$J,358.3,28343,0)
 ;;=D86.83^^132^1330^40
 ;;^UTILITY(U,$J,358.3,28343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28343,1,3,0)
 ;;=3^Sarcoid Iridocyclitis
 ;;^UTILITY(U,$J,358.3,28343,1,4,0)
 ;;=4^D86.83
 ;;^UTILITY(U,$J,358.3,28343,2)
 ;;=^5002448
 ;;^UTILITY(U,$J,358.3,28344,0)
 ;;=D84.1^^132^1330^16
 ;;^UTILITY(U,$J,358.3,28344,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28344,1,3,0)
 ;;=3^Defects in Complement System
 ;;^UTILITY(U,$J,358.3,28344,1,4,0)
 ;;=4^D84.1
 ;;^UTILITY(U,$J,358.3,28344,2)
 ;;=^5002439
 ;;^UTILITY(U,$J,358.3,28345,0)
 ;;=D81.810^^132^1330^5
 ;;^UTILITY(U,$J,358.3,28345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28345,1,3,0)
 ;;=3^Biotinidase Deficiency
 ;;^UTILITY(U,$J,358.3,28345,1,4,0)
 ;;=4^D81.810
 ;;^UTILITY(U,$J,358.3,28345,2)
 ;;=^5002422
 ;;^UTILITY(U,$J,358.3,28346,0)
 ;;=E88.01^^132^1330^2
 ;;^UTILITY(U,$J,358.3,28346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28346,1,3,0)
 ;;=3^Apha-1 Antitrypsin Deficiency
 ;;^UTILITY(U,$J,358.3,28346,1,4,0)
 ;;=4^E88.01
 ;;^UTILITY(U,$J,358.3,28346,2)
 ;;=^331442
 ;;^UTILITY(U,$J,358.3,28347,0)
 ;;=J09.X1^^132^1330^25
 ;;^UTILITY(U,$J,358.3,28347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28347,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Pneumonia
 ;;^UTILITY(U,$J,358.3,28347,1,4,0)
 ;;=4^J09.X1
 ;;^UTILITY(U,$J,358.3,28347,2)
 ;;=^5008144
 ;;^UTILITY(U,$J,358.3,28348,0)
 ;;=J09.X2^^132^1330^26
 ;;^UTILITY(U,$J,358.3,28348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28348,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Resp Manifest
 ;;^UTILITY(U,$J,358.3,28348,1,4,0)
 ;;=4^J09.X2
 ;;^UTILITY(U,$J,358.3,28348,2)
 ;;=^5008145
